Bernard Verrier

10.1k total citations · 1 hit paper
228 papers, 8.0k citations indexed

About

Bernard Verrier is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Bernard Verrier has authored 228 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 84 papers in Immunology and 58 papers in Virology. Recurrent topics in Bernard Verrier's work include HIV Research and Treatment (57 papers), Immunotherapy and Immune Responses (49 papers) and RNA Interference and Gene Delivery (38 papers). Bernard Verrier is often cited by papers focused on HIV Research and Treatment (57 papers), Immunotherapy and Immune Responses (49 papers) and RNA Interference and Gene Delivery (38 papers). Bernard Verrier collaborates with scholars based in France, United States and Germany. Bernard Verrier's co-authors include Stéphane Paul, Thierry Delair, Jean‐Yves Exposito, Céline Lacroix, Christian Genin, Nicolas Rochereau, Vincent Pavot, Claire Monge, Jean Mauchamp and Morgane Berthet and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Bernard Verrier

225 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

2010 423 citations Bernard Verrier, Roger Le Grand et al. profile →

Peers

Countries citing papers authored by Bernard Verrier

Since Specialization

Citations

This map shows the geographic impact of Bernard Verrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Verrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Verrier more than expected).

Fields of papers citing papers by Bernard Verrier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Verrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Verrier. The network helps show where Bernard Verrier may publish in the future.

Co-authorship network of co-authors of Bernard Verrier

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Verrier. A scholar is included among the top collaborators of Bernard Verrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Verrier. Bernard Verrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a pharyngeal mucosal lymphoid organ in zebrafish and other teleosts: Tonsils in fish? 2023 ·Science Advances ·Julien Rességuier, Mai Nguyen‐Chi, Jens Wohlmann, (unknown), Irene Salinas, Stefan H. Oehlers, Geert F. Wiegertjes, Finn–Eirik Johansen, Shuo‐Wang Qiao, Erling Olaf Koppang, Bernard Verrier, Pierre Boudinot, Gareth Griffiths	21
2	DLin-MC3-Containing mRNA Lipid Nanoparticles Induce an Antibody Th2-Biased Immune Response Polarization in a Delivery Route-Dependent Manner in Mice 2023 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Claire Monge, Jean‐Yves Exposito, (unknown), Bernard Verrier	15
3	Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes 2023 ·Molecules ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Evelyne Colomb, Bernard Verrier, Claire Monge, Sophie Richard	5
4	Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus 2022 ·Antiviral Research ·(unknown), (unknown), (unknown), (unknown), Simon Mégy, Evelyne Colomb, Raphaël Terreux, Julie Lucifora, David Durantel, Bernard Verrier	3
5	Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major 2022 ·Molecules ·(unknown), Noureddine Ben Khalaf, Balkiss Bouhaouala‐Zahar, Bernard Verrier, Thomas Trimaille, Zakaria Benlasfar, Mehdi Chenik, Mohamed Elayeb	7
6	Comparison of Physicochemical Properties of LipoParticles as mRNA Carrier Prepared by Automated Microfluidic System and Bulk Method 2022 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Jean‐Yves Exposito, (unknown), Claire Monge, Bernard Verrier, (unknown)	4
7	Design and Evaluation of Autophagy-Inducing Particles for the Treatment of Abnormal Lipid Accumulation 2022 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Eeva‐Liisa Eskelinen, Ganna Panasyuk, Bernard Verrier, Charlotte Primard	9
8	Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses 2021 ·Cells ·Yves Pachéco, Dominique Valeyre, Thomas El Jammal, Maxime Vallée, Fabien Chevalier, Jérôme Lamartine, Dominique Sigaudo‐Roussel, Bernard Verrier, Dominique Israël‐Biet, N. Freymond, Vincent Cottin, Alain Calender	10
9	Sublingual protein delivery by a mucoadhesive patch made of natural polymers 2021 ·Acta Biomaterialia ·(unknown), Sofia G. Caridade, Evelyne Colomb, (unknown), (unknown), Bernard Verrier, Claire Monge	24
10	Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma 2020 ·Cancers ·(unknown), (unknown), (unknown), Agnès Paquet, Dominique Douguet, (unknown), Delphine Debayle, Audrey Di Giorgio, Valérie Biou, Christophe A. Girard, Maria Duca, Lionel Brétillon, Corine Bertolotto, Bernard Verrier, Stéphane Azoulay, Isabelle Mus‐Veteau	13
11	Comparison of four different fuller's earth formulations in skin decontamination 2017 ·Journal of Applied Toxicology ·(unknown), (unknown), Marie‐Paule Gustin, (unknown), Bernard Verrier, Fabrice Pirot, Françoise Falson	14
12	Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting 2016 ·Vaccines ·Alice Gutjahr, (unknown), (unknown), Claire Monge, (unknown), Stéphane Paul, Bernard Verrier	106
13	Co-delivery of Antigen p24 and NOD-ligands by PLA Nanoparticles to Human Dendritic Cells Promote Highly Functional HIV-1-Specific T-cell Responses 2014 ·AIDS Research and Human Retroviruses ·Núria Climent, Vincent Pavot, Felipe García, Thierry Lioux, Éric Pérouzel, Charlotte Primard, Stéphane Paul, José María Gatell, Montserrat Plana, Bernard Verrier, Teresa Gallart	1
14	Lung Dendritic Cells Rapidly Mediate Anthrax Spore Entry through the Pulmonary Route 2007 ·The Journal of Immunology ·(unknown), Anne Quesnel‐Hellmann, Alexandra Vallon-Eberhard, Bernard Verrier, Steffen Jung, Dominique Vidal, Jacques Mathieu, Jean‐Nicolas Tournier	114
15	Transepithelial Pathogen Uptake into the Small Intestinal Lamina Propria 2006 ·The Journal of Immunology ·Alexandra Vallon-Eberhard, Limor Landsman, Nir Yogev, Bernard Verrier, Steffen Jung	155
16	Evidence for CTL-Mediated Selection of Tat and Rev Mutants after the Onset of the Asymptomatic Period during HIV Type 1 Infection 2006 ·AIDS Research and Human Retroviruses ·Christophe Guillon, K. Stankovic, Yasemin Ataman‐Önal, F. Biron, Bernard Verrier	17
17	Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08 2002 ·DNA and Cell Biology ·Bernard Verrier, Roger Le Grand, Yasemin Ataman‐Önal, (unknown), Christophe Guillon, (unknown), Bruno Hurtrel, Anné-Marie Aubertin, Gerd Sutter, Volker Erfle, Marc Girard	37
18	Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line 1995 ·Journal of Cellular Physiology ·Olivier Delézay, Bernard Verrier, Kamel Mabrouk, J. Van Rietschoten, Jacques Fantini, Jean Mauchamp, Corinne Gérard	19
19	Combination of culture on collagen gels and glucose starvation for cloning human colon cancer cells 1991 ·Cytotechnology ·Maxime Lehmann, (unknown), J. B. Rognoni, Bernard Verrier, Jacques Marvaldi, Jacques Fantini	2
20	Thyrotropin-receptor interaction and cyclic AMP-mediated effects in thyroid cells. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Serge Lissitzky, G. Fayet, Bernard Verrier	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact